Related Experiment Video

Updated: May 16, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

eComment. Should persistent N2/N3 non-small cell lung cancer be treated by surgery?

Alessandro Baisi1, Federico Raveglia, Matilde De Simone

  • 1Thoracic Unit, Ospedale San Paolo Milano, University of Milan, Milan, Italy.

Interactive Cardiovascular and Thoracic Surgery
|November 21, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Experiment Videos

Last Updated: May 16, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Redefining the concept of resectability in the landscape of perioperative treatments for lung cancer.

Frontiers in oncology·2026

Robotic-Assisted Thoracic Surgery in the Immunotherapy Era: Navigating Altered Anatomy, Oncologic Precision, and the Future of Integrated Platforms.

Journal of clinical medicine·2026

The Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.

Oncology research·2026

Robotic ramicotomy for palmar and axillary hyperhidrosis.

Multimedia manual of cardiothoracic surgery : MMCTS·2026

Near Misses as Signals of System Vulnerability in Thoracic Surgery: A Narrative Review on Quality Improvement and Patient Safety.

Healthcare (Basel, Switzerland)·2026

Treatment of Malignant Tracheobronchial Stenosis with Y-Shaped Stent: A Multicenter Retrospective Study.

Journal of clinical medicine·2026

Association of liver dysfunction with outcomes after cardiac surgery-a meta-analysis.

Interactive cardiovascular and thoracic surgery·2022

Continuous vagal intraoperative neuromonitoring during video-assisted thoracoscopic surgery for left lung cancer: its efficacy in preventing permanent vocal cord paralysis.

Interactive cardiovascular and thoracic surgery·2022

Postoperative aortic injury caused by a staple line formed during wedge resection of the lung.

Interactive cardiovascular and thoracic surgery·2022

Surgical management of cardiac cystic echinococcosis in a paediatric patient: a case report.

Interactive cardiovascular and thoracic surgery·2022

Does the division of the inferior pulmonary ligament in upper lobectomy result in improved short-term clinical outcomes and long-term survival?

Interactive cardiovascular and thoracic surgery·2022

Transfusions and early outcomes in anaemic patients undergoing off- or on-pump coronary artery bypass grafting.

Interactive cardiovascular and thoracic surgery·2022
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us